Skip to main content
ANGIODYNAMICS INC logo

ANGIODYNAMICS INC — Investor Relations & Filings

Ticker · ANGO ISIN · US03475V1017 LEI · 549300W3VKC5ZKMO8C28 US Manufacturing
Open in API
Filings indexed 1,054 across all filing types
Latest filing 2026-04-23 Legal Proceedings Report
Country US United States of America
Listing US ANGO

About ANGIODYNAMICS INC

https://www.angiodynamics.com/

AngioDynamics Inc. is a medical technology company focused on developing, manufacturing, and selling innovative, minimally invasive devices. The company's core activities center on restoring healthy blood flow in the vascular system and expanding cancer treatment options. Its product portfolio serves healthcare professionals such as interventional radiologists, cardiologists, and surgeons. Key technology platforms include the Auryon System, an advanced peripheral atherectomy device; the AlphaVac System for mechanical thrombectomy; and the NanoKnife System for precise, non-thermal tumor ablation. AngioDynamics is dedicated to improving patient outcomes through technologies designed for vascular access, peripheral vascular disease, and oncology.

Recent filings

Filing Released Lang Actions
8-K - ANGIODYNAMICS INC (0001275187) (Filer)
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 23, 2026, by AngioDynamics, Inc. It reports the commencement of a patent infringement lawsuit against another company. The content focuses on legal proceedings and the company's assertion of intellectual property rights. There are no financial statements, earnings data, or management discussion of financial results. The document is not a report of financial performance but a regulatory announcement about legal matters. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 4783 characters, which is sufficient to contain substantive content, not just a brief announcement or certification. Hence, the classification is LTR with high confidence.
2026-04-23 English
10-Q - ANGIODYNAMICS INC (0001275187) (Filer)
Interim / Quarterly Report 9M 2026
2026-04-02 English
8-K - ANGIODYNAMICS INC (0001275187) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 2, 2026, by AngioDynamics, Inc. It announces the issuance of a press release with financial results for the fiscal third quarter ended February 28, 2026, and includes presentation slides related to the same quarter. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release and presentation as exhibits. The text explicitly states that the press release and presentation are "furnished" and not "filed" for certain regulatory purposes, indicating this is an announcement of results rather than the full report. The length is 6854 characters, which is relatively short and consistent with a current report announcement. Therefore, this filing is best classified as a Regulatory Filing (RNS) since it is a current report announcing financial results and related materials but does not contain the full financial report or detailed financial data itself.
2026-04-02 English
SCHEDULE 13G/A - ANGIODYNAMICS INC (0001275187) (Subject)
Major Shareholding Notification
2026-03-26 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-13 English
SCHEDULE 13G - ANGIODYNAMICS INC (0001275187) (Subject)
Major Shareholding Notification
2026-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.